Related Experiment Video
Updated: Jun 11, 2025

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Hypothermia for Cardioprotection in Acute Coronary Syndrome Patients: From Bench to Bedside
Nikolaos Pyrpyris1, Kyriakos Dimitriadis1, Panagiotis Iliakis1
1First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece.
Insights
Early revascularization is crucial for acute myocardial infarction (AMI) patients. Intracoronary selective hypothermia shows promise in limiting reperfusion injury, a key factor in heart damage.
Area of Science:
- Cardiology
- Cardiovascular Research
- Medical Technology
Background:
- Early revascularization is vital for acute myocardial infarction (AMI) patients to improve outcomes.
- Myocardial reperfusion injury can paradoxically increase infarct size and complications.
- Existing strategies like systemic hypothermia have limitations.
Purpose of the Study:
- To review the pathophysiology of myocardial reperfusion injury.
- To explore hypothermia's cardioprotective mechanisms.
- To evaluate systemic and selective hypothermia for myocardial protection.
Main Methods:
- Review of animal models and clinical studies on hypothermia.
- Analysis of preclinical and clinical data for intracoronary selective hypothermia.
- Discussion of pathophysiology and cardioprotective mechanisms.
Main Results:
- Hypothermia can limit infarct size increase in animal models when applied before reperfusion.
- Systemic hypothermia has shown limited benefit due to adverse events and inadequate cooling.
- Intracoronary selective hypothermia is emerging as a promising novel technique.
Conclusions:
- Myocardial reperfusion injury is a significant clinical challenge.
- Intracoronary selective hypothermia presents a novel and potentially effective strategy for cardioprotection.
- Further research into selective hypothermia is warranted for clinical application.
Abstract:
Early revascularization for patients with acute myocardial infarction (AMI) is of outmost importance in limiting infarct size and associated complications, as well as for improving long-term survival and outcomes. However, reperfusion itself may further damage the myocardium and increase the infarct size, a condition commonly recognized as myocardial reperfusion injury. Several strategies have been developed for limiting the associated with reperfusion myocardial damage, including hypothermia. Hypothermia has been shown to limit the degree of infarct size increase, when started before reperfusion, in several animal models. Systemic hypothermia, however, failed to show any benefit, due to adverse events and potentially insufficient myocardial cooling. Recently, the novel technique of intracoronary selective hypothermia is being tested, with preclinical and clinical results being of particular interest. Therefore, in this review, we will describe the pathophysiology of myocardial reperfusion injury and the cardioprotective mechanics of hypothermia, report the animal and clinical evidence in both systemic and selective hypothermia and discuss the potential future directions and clinical perspectives in the context of cardioprotection for myocardial reperfusion injury.
Related Concept Videos
Decreased Body Temperature
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Introduction Cardiac Emergencies
Acute Coronary Syndrome V: Nursing Management
Acute Coronary SyndromeI: Introduction

